Martin P Carroll

15PUBLICATIONS
182CO-AUTHORS
Gene and molecular therapyHaematological tumoursMolecular targetsPredictive and prognostic markersMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Oct 10, 2026
HLA-A*11:01-Restricted T Cell Receptors Targeting Mutant NPM1 for Adoptive Cell Therapy in Acute Myeloid Leukemia.

|Oct 06, 2026
A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist.

|Oct 01, 2026
Somatic DDX41 mutations confer neomorphic splicing activity in the pathogenesis of myelodysplastic neoplasms.

|Nov 24, 2025
Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphate.

Roberta Buono, Dennis Juarez, Madhuri Paul

|Jul 09, 2025
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response.

Sarah J Skuli, A'ishah Bakayoko, Marisa Kruidenier

|May 07, 2024
A mitochondrial surveillance mechanism activated by SRSF2 mutations in hematologic malignancies.

Xiaolei Liu, Sudhish A Devadiga, Robert F Stanley

Pageof 3

Frequent Collaborators

3 joint publications

Pamela J Sung

3 joint publications

Jean-Emmanuel Sarry

2 joint publications

Mathieu Quesnel-Vallières

2 joint publications

David A Fruman